Product Information
GS LANSOPRAZOLE DR 15 MG CAP is a generic product labeled by L. Perrigo Company, priced at $0.4067 per EA under NDC 00113111403. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on May 18, 2012.
Strength
15 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113111403
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202319FDA Approved
5/18/2012
On Market Since
11/22/2021
Pharmacological Classes
Price Statistics
The NADAC for GS LANSOPRAZOLE DR 15 MG CAP has been published 86 times since Feb 12, 2025, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4067 per EA |
|---|---|
| All-time high | $0.4740 (Apr 16, 2025) |
| All-time low | $0.4067 (Sep 23, 2026) |
| 52-week high | $0.4629 |
| 52-week low | $0.4067 |
| Median price | $0.4427 |
| Average price | $0.4433 |
| Largest weekly change | -6.1% (Aug 19, 2026) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS LANSOPRAZOLE DR 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for GS LANSOPRAZOLE DR 15 MG CAP, manufactured by L. Perrigo Company, is $0.4067 per EA (NDC 00113111403), effective Sep 30, 2026.
How has the price of GS LANSOPRAZOLE DR 15 MG CAP changed over time?
Over the history we have for it, the NADAC for GS LANSOPRAZOLE DR 15 MG CAP has declined 13.2%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for GS LANSOPRAZOLE DR 15 MG CAP?
Since Feb 12, 2025, the NADAC for GS LANSOPRAZOLE DR 15 MG CAP has ranged from a low of $0.4067 (Sep 23, 2026) to a high of $0.4740 (Apr 16, 2025), with a median of $0.4427 per EA.
Are there cheaper alternatives to GS LANSOPRAZOLE DR 15 MG CAP?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 15 MG CAPSULE, is $0.1474 per EA — about 64% below GS LANSOPRAZOLE DR 15 MG CAP.
Who manufactures GS LANSOPRAZOLE DR 15 MG CAP?
GS LANSOPRAZOLE DR 15 MG CAP (NDC 00113111403) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.